Header Logo

Connection

ANDREW LEE to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications ANDREW LEE has written about Cost-Benefit Analysis.
ANDREW LEE
Connection Strength
0.238
Cost-Benefit Analysis
  1. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
    View in: PubMed
    Score: 0.145
  2. Evaluation and neuroimaging of the Horner syndrome. Can J Ophthalmol. 2015 Apr; 50(2):107-11.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.